DJ Amgen Inc. Stock Underperforms Wednesday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Amgen Inc. $(AMGN)$ slid 1.78% to $341.66 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 1.21% to 7,420.10 and Dow Jones Industrial Average falling 0.98% to 51,492.55.
This was the stock's third consecutive day of losses.
Amgen Inc. closed 12.68% below its 52-week high of $391.29, which the company reached on March 2nd.
The stock underperformed when compared to some of its competitors Wednesday, as Johnson & Johnson $(JNJ)$ fell 0.42% to $234.20, Pfizer Inc. $(PFE)$ fell 0.46% to $25.92, and AbbVie Inc. $(ABBV)$ fell 0.56% to $221.23.
Trading volume (3.3 M) eclipsed its 50-day average volume of 2.7 M.
Data source: Dow Jones Market Data, FactSet. Data compiled June 17, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
June 17, 2026 16:35 ET (20:35 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.